Literature DB >> 19139187

18F-FDG PET and PET/CT in the evaluation of cancer treatment response.

Simona Ben-Haim1, Peter Ell.   

Abstract

Multimodality imaging, as represented by its greatest exponent, PET/CT, has a firm place in the evaluation of a patient presenting with cancer. With 18F-FDG, PET/CT is rapidly becoming the key investigative tool for the staging and assessment of cancer recurrence. In the last 5 y, PET/CT has also gained widespread acceptance as a key tool used to demonstrate early response to intervention and therapy. In this setting, a major clinical need is being addressed with 18F-FDG PET/CT, because of its inherent ability to demonstrate (before other markers of response) if disease modification has occurred. This review presents available evidence to this effect.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19139187     DOI： 10.2967/jnumed.108.054205

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


  113 in total

1.  Evaluation of the spatial dependence of the point spread function in 2D PET image reconstruction using LOR-OSEM.

Authors:  D Wiant; J A Gersh; M Bennett; J D Bourland
Journal:  Med Phys       Date:  2010-03       Impact factor: 4.071

2.  On the significance of defective block detectors in clinical (18)F-FDG PET/CT imaging.

Authors:  Esmat Elhami; Maryam Samiee; Sandor Demeter; William D Leslie; Andrew L Goertzen
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488

Review 3.  In vivo imaging in cancer.

Authors:  John Condeelis; Ralph Weissleder
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-09-22       Impact factor: 10.005

4.  Exploiting tumor metabolism: challenges for clinical translation.

Authors:  Matthew G Vander Heiden
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 5.  Multiplexed imaging in cancer diagnosis: applications and future advances.

Authors:  Hisataka Kobayashi; Michelle R Longmire; Mikako Ogawa; Peter L Choyke; Satomi Kawamoto
Journal:  Lancet Oncol       Date:  2010-03-24       Impact factor: 41.316

6.  Evaluation of response: is 18F-FDG PET the answer?

Authors:  Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05       Impact factor: 9.236

Review 7.  Machine learning in quantitative PET: A review of attenuation correction and low-count image reconstruction methods.

Authors:  Tonghe Wang; Yang Lei; Yabo Fu; Walter J Curran; Tian Liu; Jonathon A Nye; Xiaofeng Yang
Journal:  Phys Med       Date:  2020-07-29       Impact factor: 2.685

8.  Identification of small molecule inhibitors of pyruvate kinase M2.

Authors:  Matthew G Vander Heiden; Heather R Christofk; Eli Schuman; Alexander O Subtelny; Hadar Sharfi; Edward E Harlow; Jun Xian; Lewis C Cantley
Journal:  Biochem Pharmacol       Date:  2009-12-11       Impact factor: 5.858

9.  Chemical Approach to Positional Isomers of Glucose-Platinum Conjugates Reveals Specific Cancer Targeting through Glucose-Transporter-Mediated Uptake in Vitro and in Vivo.

Authors:  Malay Patra; Samuel G Awuah; Stephen J Lippard
Journal:  J Am Chem Soc       Date:  2016-09-16       Impact factor: 15.419

10.  Serial diffusion MRI to monitor and model treatment response of the targeted nanotherapy CRLX101.

Authors:  Thomas S C Ng; David Wert; Hargun Sohi; Daniel Procissi; David Colcher; Andrew A Raubitschek; Russell E Jacobs
Journal:  Clin Cancer Res       Date:  2013-03-26       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.